Purdue Pharma also said it will cut its sales force by about half.
Marketing efforts will be directed at a treatment for opioid-induced constipation, the company said.
OxyContin will no longer be marketed to doctors after states leveled drugmaker Purdue Pharma with lawsuits.
Purdue Pharma announced that it will be cutting OxyContin sales staff in an effort to stop promoting the drug to prescribers and pharmacies in the U.S. The company has been accused of using controversial marketing practices that fal...
The maker of painkiller OxyContin will stop promoting opioid drugs to doctors and will slash its sales force by half, a decision that follows the company receiving a barrage of lawsuits that cite the ongoing opioid epidemic.